Ontology highlight
ABSTRACT: Background
Catheter ablation is an established therapy for atrial fibrillation but is limited by recurrence; efforts have been made to identify biomarkers that predict recurrence. We investigated the effect of baseline NT-proBNP on AF recurrence following catheter ablation in patients randomized to aggressive (< 120/80 mmHg) or standard blood pressure management (< 140/90 mmHg) in the Substrate Modification with Aggressive Blood Pressure Control trial (SMAC-AF).Methods
The SMAC-AF study included 173 patients resistant or intolerant to at least one class I or III antiarrhythmic drug. We studied the effect of baseline NT-proBNP on the primary outcome of AF recurrence > 3 months post-ablation.Results
Of the 173 patients, 88 were randomized to the aggressive cohort, and
SUBMITTER: Weng W
PROVIDER: S-EPMC8447763 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature